EUVIMEDEUVIMED entdecken
Crossref

Clinical and Functional Significance of C16orf74 in Extrahepatic Cholangiocarcinoma

Kotaro Kimura, Toru Nakamura, Toshihiro Kushibiki, Masakazu Fujii, Tomotaka Kuraya, Hiroki Niwa, Yoshitsugu Nakanishi, Shintaro Takeuchi, Katsunori Sasaki, Kanako C Hatanaka, Yutaka Hatanaka, Masataka Wada und 6 weitere

Anticancer Research · 2026-08 · 46 (8) · 4251-4265

DOI: 10.21873/anticanres.18284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Kotaro Kimura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsHumansAnimalsFemaleMaleMiddle AgedAgedMiceCell Line, TumorPrognosisCell ProliferationCell MovementXenograft Model Antitumor AssaysProto-Oncogene Proteins c-aktBiomarkers, TumorGene Expression Regulation, NeoplasticSignal Transduction

Stichwörter der Autor:innen

C16orf74Extrahepatic cholangiocarcinomabiliary tract cancerdimer-blocking peptidemolecular targeted therapy

Substanzen

Proto-Oncogene Proteins c-aktBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan; torunakamura@med.hokudai.ac.jp.
  • Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
  • Center for Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan.

Zitieren

APA

Kimura, K., Nakamura, T., Kushibiki, T., Fujii, M., Kuraya, T., Niwa, H., Nakanishi, Y., Takeuchi, S., Sasaki, K., Hatanaka, K. C., Hatanaka, Y., Wada, M., Matsui, A., Tanaka, K., Asano, T., Noji, T., Tsuchikawa, T., & Hirano, S. (2026). Clinical and Functional Significance of C16orf74 in Extrahepatic Cholangiocarcinoma. Anticancer Research, 46(8), 4251-4265. https://doi.org/10.21873/anticanres.18284

Vancouver

Kimura K, Nakamura T, Kushibiki T, Fujii M, Kuraya T, Niwa H, et al. Clinical and Functional Significance of C16orf74 in Extrahepatic Cholangiocarcinoma. Anticancer Research. 2026;46(8):4251-4265. doi:10.21873/anticanres.18284

BibTeX
@article{Kimura2026,
  author = {Kimura, Kotaro and Nakamura, Toru and Kushibiki, Toshihiro and Fujii, Masakazu and Kuraya, Tomotaka and Niwa, Hiroki and Nakanishi, Yoshitsugu and Takeuchi, Shintaro and Sasaki, Katsunori and Hatanaka, Kanako C and Hatanaka, Yutaka and Wada, Masataka and Matsui, Aya and Tanaka, Kimitaka and Asano, Toshimichi and Noji, Takehiro and Tsuchikawa, Takahiro and Hirano, Satoshi},
  title = {Clinical and Functional Significance of C16orf74 in Extrahepatic Cholangiocarcinoma},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {4251--4265},
  doi = {10.21873/anticanres.18284}
}
Kostenlos starten →